Skip to main content

Needle-free, painless vaccinations may become a reality thanks to MucoJet

A painless way to give vaccines
No one likes getting vaccinated but it’s a lot better than getting sick. Putting aside the concerns some have about the supposed risks of vaccines, let’s recognize that they’ve saved millions of children from diseases in the United States alone, according to the Center for Disease Control. So vaccinations are pretty great.

Injections, however, are pretty damn painful, especially for tiny tots who are most at risk of disease. That might change within a decade though thanks to a needle-free device called the MucoJet that make vaccinations practically painless. Developed by researchers in Dorian Liepmann’s lab at the University of California, Berkeley, the pill-sized, 3D-printed device shoots a stream of vaccine into the tissue of the cheek.

Related Videos

To activate the MucoJet, a patient first need to squeeze the device together, creating a reaction and increasing pressure inside. The patient then holds the device on the inside of her cheek for about ten seconds, at which point the pressure breaks a membrane and shoots a concentrated stream of vaccine through a small nozzle.

The MucoJet is needle-free (and thus virtually painless) and may also be able to address viruses more effectively than conventional techniques, according to Kiana Aran, a professor of mechanical and bioengineering who developed the MucoJet while working in Liepmann’s lab.

“The majority of modern vaccines are injected intramuscularly or subcutaneously, although the majority of pathogens actually access the body via the mucosal surfaces,” she told Digital Trends. A few vaccines are administered through the mucosal surfaces — including oral polio and rotavirus vaccine but, Aran said, these have limited safety and utility since they contain live viral components. With MucoJet, the researchers think they may be able to design safer and more effective mucosal vaccines.

So far, the researchers have demonstrated a proof of concept, successfully delivering vaccine-size molecules to cells in the mouths of animals. A paper describing the device was published last week in the journal Science Translational Medicine. Future research will entail testing the MucoJet on larger animals, such as monkeys and pigs. The researchers think the product may come to market in the next five to ten years.

Editors' Recommendations

Fauci says things might not go back to normal until the end of 2021
medical employee holding mask stylized image

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, warned Friday that the world might not go back to normal any time soon, as the development of a vaccine against the coronavirus pandemic continues.

Fauci said in an interview with MSNBC's Andrea Mitchell that it may take more than a year to return "to a degree of normality" that resembles the situation before the pandemic.

Read more
Twitter removes coronavirus misinformation that Trump shared
Trump stylized image

A tweet shared by President Donald Trump was removed by Twitter for violating community guidelines about sharing false statistics and misinformation about the coronavirus.

Originally posted to the site by a QAnon supporter, the removed tweet claimed the Centers for Disease Control and Prevention (CDC) “updated its number” to show only 6% of COVID-19 deaths were from the disease, while the rest were due to “other serious illnesses.” The tweet was retweeted by the president.

Read more
Florida will release gene-edited mosquitoes into the wild, despite outcry
johns hopkins mosquitoes crispr mosquito swarm

Dengue, mosquitos and the Oxitec approach - part 2

Hundreds of millions of genetically engineered mosquitoes will soon be purposely set loose in the Florida Keys in what those opposed to the venture are calling a “Jurassic Park experiment” in action.

Read more